Healthcare

Elizabeth Holmes, the shamed founder of defunct health tech startup Theranos, faces criminal fraud charges. Is she still a billionaire?

In the last year, T2 Biosystems stock has risen 36 percent. Is TTOO stock a good buy at this price? How's the company's outlook and what can investors expect?

Vegan oat milk brand Oatly may pursue an IPO in 2021, potentially raising $1 billion.

The FDA approved Janssen Pharmaceuticals’ application to conduct a clinical trial of its COVID vaccine candidate in the Philippines. Is Janssen Pharmaceuticals publicly traded?

You may not even realize it, but you may be eligible to save money on AstraZeneca prescriptions from the AZ&Me prescription savings program.

AstraZeneca is a leading biopharmaceutical company that focuses on developing drugs to treat cancer, heart disease, and COPD. What drugs does the company make?

There were a total of six deaths in the late-stage clinical trial for Pfizer’s COVID-19 vaccine. So, is Pfizer’s COVID-19 vaccine safe and effective?

Peloton stationary bikes cost upwards of $2,000 and require a monthly subscription. Why is Peloton so expensive?

Green energy and marijuana stocks have rallied after Biden's election. What are the best cannabis stocks to buy for 2021?

Biogen, which is an American multinational biotechnology company, was the S&P 500’s top loss on June 18.

Vertex Pharmaceuticals (VRTX) reported its 2Q16 earnings on July 27, 2016. VRTX surpassed Wall Street analysts’ projections and reported revenue of $431.6 million.

Spark Therapeutics generated revenues of $25.18 million in the second quarter of 2018 compared to $1.48 million in Q2 2017.

Teva Pharmaceutical’s net income and diluted EPS in the first nine months of 2018 amounted to $541.0 million and $0.53, respectively.

AbbVie (ABBV) generated net revenue of $7.9 billion in 1Q18 compared to $6.5 billion in 1Q17.

UnitedHealth Group is a leading managed healthcare firm in the United States.

Chilton started a new position in aerospace engineering company TransDigm Group Inc. (TDG) that accounts for 0.76% of the fund’s fourth quarter portfolio.

Approximately 63% of Wyndham’s revenues come from fees for providing services referred to as its “fee-for-service” businesses.

Pershing Square disclosed a new position in Platform Specialty Products (PAH) that accounts for 7.58% of Pershing Square’s 1Q14 portfolio.

Spark Therapeutics’ (ONCE) operating expenses decreased from $78.48 million in Q2 2017 to $59.78 million in Q2 2018.

Extra Space (EXR) holds 12% of its total properties in the form of joint ventures and 32% managed for third parties—the largest in the industry.

There's a lot of interest in COVID-19 vaccines. Where is Pfizer's COVID-19 vaccine being made? When will the vaccine be authorized and available?

Butterfly Network, a digital health company, is about to go public through a SPAC IPO. When is its IPO date?

Xtandi is the major factor behind Pfizer’s (PFE) interest in Medivation (MDVN). The drug, along with MDVN’s pipeline molecules, should strengthen Pfizer’s (PFE) oncology franchise.

On September 14, Boston Scientific (BSX) was trading at a forward price-to-earnings ratio of 24.4x, compared to the industry’s average PE ratio of 22.4x.

The company has delivered a robust financial performance in recent quarters. However, the stock has been on a bearish trend during the recent period.

Medivation’s portfolio complements Pfizer’s existing oncology portfolio that includes solid tumors, hematology, and immunology-oncology.

Boston Scientific (BSX) announced the acquisition of Veniti for $108.0 million. BSX already owns a 25% stake in Veniti.

Bausch Health plans to spin off its eye care division, Bausch + Lomb, into a standalone public company in a bid to unlock value for shareholders.

Tandem Diabetes Care (TNDM) is slated to begin its international expansion later this year to capture opportunities arising after Johnson & Johnson’s (JNJ) exit from the insulin pump market, which was announced in October 2017.

Increased life expectancy means a longer investment horizon. With life expectancy increasing, young investors should invest in equities aggressively.

Ligand Pharmaceuticals has developed a product portfolio that spans more than 700 patents offering varying degrees of protection to the assets.

Global monetary policy is unconventional. From an era of lowering interest rates to boost economic growth, central bankers are taking rates into negative territory.

In its Structural Heart business, Abbott Laboratories reported 1Q18 sales of $0.29 billion, registering YoY organic sales growth of 7.5%.

For fiscal 2018 (ended March 31, 2018), Abiomed (ABMD) has projected that its operating margins will be in the range of 22%–24%.

Alnylam Pharmaceuticals (ALNY) is currently developing three investigational therapies—Patisiran, Revusiran, and ALN-TTRsc02—for the treatment of patients with hereditary ATTR amyloidosis.

Since early August 2016, there have been rumors of a likely buyout of Biogen (BIIB) by one of the many interested suitors in the biotechnology industry.

Halcyon The Halcyon system, Varian Medical Systems’ (VAR) recently launched cancer treatment device, aims to simplify and enhance IMRT (image-guided volumetric intensity modulated radiotherapy). The device has received clearance by the FDA (US Food and Drug Administration). By next year, Varian expects to receive regulatory approvals for the device in China and Japan. For more information […]

Stock performance In this article, we’ll discuss the year-to-date (YTD) stock performance of ConocoPhillips (COP), Devon Energy (DVN), Occidental Petroleum (OXY), Anadarko Petroleum (APC), and EOG Resources (EOG), which reported the highest revenue among upstream companies in fiscal 2017. Outliers and underperformers The above image shows that ConocoPhillips (COP) is the outlier among peers. YoY […]

GlaxoSmithKline (GSK) reported a 10.9% increase in its top line in its 2Q16 earnings on July 27, 2016. It met Wall Street analysts’ estimates for revenues and EPS.

The Morningstar Global Wide Moat Focus Index has global exposure, unlike the Morningstar International Moat Index (MOTI).